Despite these contradictory findings, almost all NSCLC BRAF-mutated cases feature an adenocarcinoma morphology with a micropapillary growth pattern and strong expression of thyroid transcription factor 1 (TTF-1) [25]. Here, BRAF is linked to adenocarcinoma.